Delhi Accuses Central Govt’s Portal Of Allowing ‘Substandard’ Drug Sales, Demanded Probe Into Nationwide Implications

New Delhi: The Delhi government has responded to recent Anti-Corruption Branch (ACB) raids at LNJP Hospital regarding the alleged procurement and supply of spurious and non-standard drugs, according to sources.

They revealed that the sub-standard items in question were purchased through the Central Government’s online marketplace known as GeM (Government e Marketplace). As per finance rules, government departments are mandated to obtain products from GeM, resorting to the open market only if unavailable on the portal through tenders.

Expressing surprise, the Delhi government highlighted the presence of vendors offering sub-standard products on the GeM portal, which is overseen by the Central Government.

“All the substandard items were bought from the Central Government portal called GeM. The rules of finance have made it mandatory that Govt Departments should buy products from GeM and only if they are not available on GeM, can they be bought from open market through tenders. It is surprising that the Central Govt is allowing such Vendors on its portal who are giving sub standard products,” the statement said. 

They further underlined the significance of investigating this matter, pointing out that these products might not only be supplied to the Delhi government but also to other state and central governments. The government urged for an investigation by a central agency like the Central Bureau of Investigation (CBI) to uncover the truth about GeM.

The Ministry of Home Affairs (MHA) had recently directed a CBI probe into the alleged procurement and supply of such drugs in hospitals managed by the Delhi government and mohalla clinics. This decision followed a recommendation from Delhi’s Directorate of Vigilance to the Union Home Ministry on December 26, seeking a CBI investigation into the supply of “sub-standard” drugs to state-run hospitals. Earlier, Delhi’s Lt Governor VK Saxena had also written to the Home Ministry advocating for a CBI inquiry in this regard.

Related Posts

  • Pharma
  • July 27, 2024
  • 42 views
Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mumbai: Mankind Pharma on Thursday said it has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for…

  • Pharma
  • July 27, 2024
  • 54 views
Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Canberra: Mayne Pharma has filed a lawsuit against Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards